BOT — Botanix Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$32.81m
- AU$8.12m
- AU$33.80m
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million
Australia's Botanix Pharmaceuticals slumps to 3-year low on discounted placement
Brief: Botanix Pharmaceuticals Receives Firm Commitments For A$40 Million Two-Tranche Placement
Brief: Botanix Pharmaceuticals Requests Trading Halt
Brief: Botanix Pharmaceuticals Says Sofdra Net Revenue Amounted To A$7.1 Million In Q1 FY26
Brief: Botanix Pharmaceuticals Announces Korean Regulatory Approval Of Ecclock
Brief: Botanix Pharmaceuticals Posts Net Loss Attributable A$86.4 Million
Brief: Botanix Pharmaceuticals Ltd Says Sofdra Gross Sales Reach A$25 Million Since January
Australia's Botanix Pharmaceuticals rises on $30 million debt facility with Kreos Capital
Brief: Botanix Pharmaceuticals Signs Debt Facility With Kreos Capital
Brief: Botanix Pharmaceuticals Responds To US Pharmaceutical Pricing Announcement
Brief: Botanix Pharmaceuticals Says Received Firm Commitments For A$40 Million
Brief: Botanix Pharmaceuticals Seeks Trading Halt
Brief: Botanix Pharmaceuticals Announces Commercial Launch Of SOFDRA
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$30.9 Mln
Brief: Botanix Pharmaceuticals Posts FY Net Loss Attributable Of A$13.7 Mln